MPTP treatment significantly reduced the protein levels of SOD1 (p < 0.01), SOD2 (p < 0.0001), Nrf2 and HO-1 (both p < 0.01), indicating pronounced oxidative damage in PD mice. The gene discussed is HMOX1; the disease is Parkinson disease.